Article | September 16, 2016

Managing Increasing Complexity In The Clinical Trial Industry

clinical trial data management and risk management

By Craig Morgan NZCS, MBA (Hons), PMP, goBalto, Inc.

With outsourcing of trials estimated to exceed 70% by 20202, and recent data from clinicaltrials.gov showing 46% of registered trials being conducted entirely outside the US, as compared to 39 percent taking place in the US exclusively, it is not surprising to find 72% of clinical trials running more than one month behind schedule. 

In this constantly evolving environment it is not surprising that the task of managing global trials is more demanding than ever and increasingly requires a robust risk management strategy from the start. Interestingly, while most of the industry's risk management efforts have focused on post-marketing drug safety3, the clinical trial process holds a broad array of other potential risks that could jeopardize a company's multi-million-dollar product development investment—risks such as site staffing shortages, patient recruitment issues, logistical problems with drug supplies, or regulatory delays.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: